Published in Curr Opin Microbiol on March 10, 2010
Systems metabolic engineering of microorganisms for natural and non-natural chemicals. Nat Chem Biol (2012) 2.17
A road map for the development of community systems (CoSy) biology. Nat Rev Microbiol (2012) 1.16
Spanning high-dimensional expression space using ribosome-binding site combinatorics. Nucleic Acids Res (2013) 1.08
Synthetic biology: mapping the scientific landscape. PLoS One (2012) 1.00
Genome reduction boosts heterologous gene expression in Pseudomonas putida. Microb Cell Fact (2015) 0.91
Systems metabolic engineering, industrial biotechnology and microbial cell factories. Microb Cell Fact (2012) 0.90
Pseudomonas 2.0: genetic upgrading of P. putida KT2440 as an enhanced host for heterologous gene expression. Microb Cell Fact (2014) 0.88
Functional expression and extension of staphylococcal staphyloxanthin biosynthetic pathway in Escherichia coli. J Biol Chem (2012) 0.84
Microbial production of lactate-containing polyesters. Microb Biotechnol (2013) 0.82
Zymomonas mobilis as a model system for production of biofuels and biochemicals. Microb Biotechnol (2016) 0.81
Bioinformatics for the synthetic biology of natural products: integrating across the Design-Build-Test cycle. Nat Prod Rep (2016) 0.81
Engineering of Metabolic Pathways by Artificial Enzyme Channels. Front Bioeng Biotechnol (2015) 0.80
Synthetic sugar cassettes for the efficient production of flavonol glycosides in Escherichia coli. Microb Cell Fact (2015) 0.77
In Vitro Optimization of Enzymes Involved in Precorrin-2 Synthesis Using Response Surface Methodology. PLoS One (2016) 0.75
Metabolic engineering of Escherichia coli for direct production of 1,4-butanediol. Nat Chem Biol (2011) 3.55
Metabolic engineering of Escherichia coli for the production of L-valine based on transcriptome analysis and in silico gene knockout simulation. Proc Natl Acad Sci U S A (2007) 2.43
Thyroid nodules with initially nondiagnostic cytologic results: the role of core-needle biopsy. Radiology (2013) 2.34
Systems metabolic engineering of Escherichia coli for L-threonine production. Mol Syst Biol (2007) 2.18
Systems metabolic engineering of microorganisms for natural and non-natural chemicals. Nat Chem Biol (2012) 2.17
Metabolic engineering of Escherichia coli for enhanced production of succinic acid, based on genome comparison and in silico gene knockout simulation. Appl Environ Microbiol (2005) 2.13
Diagnostic accuracy of ultrasound and 18-F-FDG PET or PET/CT for patients with suspected recurrent papillary thyroid carcinoma. Ultrasound Med Biol (2010) 2.04
Systems biotechnology for strain improvement. Trends Biotechnol (2005) 1.98
Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease. Clin Endocrinol (Oxf) (2004) 1.96
Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs. Nat Biotechnol (2013) 1.76
The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab (2011) 1.74
The genome sequence of the capnophilic rumen bacterium Mannheimia succiniciproducens. Nat Biotechnol (2004) 1.64
The genome sequence of E. coli W (ATCC 9637): comparative genome analysis and an improved genome-scale reconstruction of E. coli. BMC Genomics (2011) 1.63
Microbial production of short-chain alkanes. Nature (2013) 1.61
Constraints-based genome-scale metabolic simulation for systems metabolic engineering. Biotechnol Adv (2009) 1.60
Native-sized recombinant spider silk protein produced in metabolically engineered Escherichia coli results in a strong fiber. Proc Natl Acad Sci U S A (2010) 1.51
Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery. Mol Syst Biol (2011) 1.50
Detection of the most common corneal dystrophies caused by BIGH3 gene point mutations using a multispot gold-capped nanoparticle array chip. Anal Chem (2010) 1.41
Recent advances in reconstruction and applications of genome-scale metabolic models. Curr Opin Biotechnol (2011) 1.41
MetaFluxNet: the management of metabolic reaction information and quantitative metabolic flux analysis. Bioinformatics (2003) 1.40
Comparative multi-omics systems analysis of Escherichia coli strains B and K-12. Genome Biol (2012) 1.37
Metabolic engineering of Escherichia coli for the production of polylactic acid and its copolymers. Biotechnol Bioeng (2010) 1.36
Identification and characterization of a new enoyl coenzyme A hydratase involved in biosynthesis of medium-chain-length polyhydroxyalkanoates in recombinant Escherichia coli. J Bacteriol (2003) 1.35
Genome-scale reconstruction and in silico analysis of the Clostridium acetobutylicum ATCC 824 metabolic network. Appl Microbiol Biotechnol (2008) 1.34
Systems biology as a foundation for genome-scale synthetic biology. Curr Opin Biotechnol (2006) 1.31
Application of systems biology for bioprocess development. Trends Biotechnol (2008) 1.30
Complete genome sequence of the metabolically versatile plant growth-promoting endophyte Variovorax paradoxus S110. J Bacteriol (2010) 1.29
Genome-scale analysis of Mannheimia succiniciproducens metabolism. Biotechnol Bioeng (2007) 1.28
Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol (Oxf) (2009) 1.27
Organizational and mutational analysis of a complete FR-008/candicidin gene cluster encoding a structurally related polyene complex. Chem Biol (2003) 1.27
Metabolite essentiality elucidates robustness of Escherichia coli metabolism. Proc Natl Acad Sci U S A (2007) 1.26
Bio-based production of C2-C6 platform chemicals. Biotechnol Bioeng (2012) 1.25
Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation. Clin Endocrinol (Oxf) (2004) 1.24
Combined transcriptome and proteome analysis of Escherichia coli during high cell density culture. Biotechnol Bioeng (2003) 1.24
Enhanced butanol production obtained by reinforcing the direct butanol-forming route in Clostridium acetobutylicum. MBio (2012) 1.24
The Escherichia coli proteome: past, present, and future prospects. Microbiol Mol Biol Rev (2006) 1.23
Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab (2008) 1.23
Metabolic engineering of Escherichia coli for the production of cadaverine: a five carbon diamine. Biotechnol Bioeng (2011) 1.21
Genome-based metabolic engineering of Mannheimia succiniciproducens for succinic acid production. Appl Environ Microbiol (2006) 1.21
In silico identification of gene amplification targets for improvement of lycopene production. Appl Environ Microbiol (2010) 1.18
Systems metabolic engineering for chemicals and materials. Trends Biotechnol (2011) 1.17
Proteome-based identification of fusion partner for high-level extracellular production of recombinant proteins in Escherichia coli. Biotechnol Bioeng (2008) 1.16
Papillary thyroid carcinoma arising from a thyroglossal duct cyst: a single institution experience. Endocr J (2013) 1.16
Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population. Eur J Endocrinol (2013) 1.16
Patterned multiplex pathogen DNA detection by Au particle-on-wire SERS sensor. Nano Lett (2010) 1.15
Biosynthesis of polylactic acid and its copolymers using evolved propionate CoA transferase and PHA synthase. Biotechnol Bioeng (2010) 1.14
Novel gene members in the Pho regulon of Escherichia coli. FEMS Microbiol Lett (2006) 1.13
BioSilico: an integrated metabolic database system. Bioinformatics (2004) 1.12
18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm. J Clin Endocrinol Metab (2007) 1.11
Continuous butanol production with reduced byproducts formation from glycerol by a hyper producing mutant of Clostridium pasteurianum. Appl Microbiol Biotechnol (2011) 1.08
Metabolite-centric approaches for the discovery of antibacterials using genome-scale metabolic networks. Metab Eng (2009) 1.07
Towards systems metabolic engineering of microorganisms for amino acid production. Curr Opin Biotechnol (2008) 1.07
Applications of DNA microarray in disease diagnostics. J Microbiol Biotechnol (2009) 1.07
Genome-scale metabolic model of methylotrophic yeast Pichia pastoris and its use for in silico analysis of heterologous protein production. Biotechnol J (2010) 1.07
Fermentative production of branched chain amino acids: a focus on metabolic engineering. Appl Microbiol Biotechnol (2010) 1.06
Microbial production of building block chemicals and polymers. Curr Opin Biotechnol (2011) 1.06
Prediction of novel synthetic pathways for the production of desired chemicals. BMC Syst Biol (2010) 1.05
Metabolic engineering of Escherichia coli for the production of putrescine: a four carbon diamine. Biotechnol Bioeng (2009) 1.05
Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects. Clin Endocrinol (Oxf) (2008) 1.05
Metabolic engineering of Clostridium acetobutylicum ATCC 824 for isopropanol-butanol-ethanol fermentation. Appl Environ Microbiol (2011) 1.05
DNA microarray-based identification of bacterial and fungal pathogens in bloodstream infections. Mol Cell Probes (2009) 1.04
Metabolic engineering of microorganisms: general strategies and drug production. Drug Discov Today (2008) 1.04
Enhanced production of insulin-like growth factor I fusion protein in Escherichia coli by coexpression of the down-regulated genes identified by transcriptome profiling. Appl Environ Microbiol (2003) 1.03
Comparison of the extracellular proteomes of Escherichia coli B and K-12 strains during high cell density cultivation. Proteomics (2008) 1.02
Genome-scale metabolic network analysis and drug targeting of multi-drug resistant pathogen Acinetobacter baumannii AYE. Mol Biosyst (2009) 1.02
Low levels of serum vitamin D3 are associated with autoimmune thyroid disease in pre-menopausal women. Thyroid (2014) 1.01
Technical and oncologic safety of robotic thyroid surgery. Ann Surg Oncol (2013) 1.01
Metabolic engineering of Escherichia coli for the production of 1-propanol. Metab Eng (2012) 1.00
Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatment. Thyroid (2012) 1.00
Butanol production from renewable biomass: rediscovery of metabolic pathways and metabolic engineering. Biotechnol J (2011) 1.00
The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma. Eur J Endocrinol (2013) 0.99
Metabolic engineering of Escherichia coli for the production of 5-aminovalerate and glutarate as C5 platform chemicals. Metab Eng (2012) 0.99
Clinical characteristics of primary thyroid lymphoma in Koreans. Endocr J (2009) 0.98
Engineering of microorganisms for the production of biofuels and perspectives based on systems metabolic engineering approaches. Biotechnol Adv (2011) 0.98
NRAS codon 61 mutation is associated with distant metastasis in patients with follicular thyroid carcinoma. Thyroid (2014) 0.98
Development of a markerless gene knock-out system for Mannheimia succiniciproducens using a temperature-sensitive plasmid. FEMS Microbiol Lett (2007) 0.97
Excretion of human beta-endorphin into culture medium by using outer membrane protein F as a fusion partner in recombinant Escherichia coli. Appl Environ Microbiol (2002) 0.97
Metabolic engineering of Clostridium acetobutylicum M5 for highly selective butanol production. Biotechnol J (2009) 0.96
A well-ordered flower-like gold nanostructure for integrated sensors via surface-enhanced Raman scattering. Nanotechnology (2009) 0.96
Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan. J Clin Endocrinol Metab (2010) 0.95
The proteome of Mannheimia succiniciproducens, a capnophilic rumen bacterium. Proteomics (2006) 0.95
WebCell: a web-based environment for kinetic modeling and dynamic simulation of cellular networks. Bioinformatics (2006) 0.95
Systemic inflammatory syndrome and hepatic inflammatory cell infiltration caused by an interleukin-6 producing pheochromocytoma. Endocr J (2005) 0.95
The genome-scale metabolic network analysis of Zymomonas mobilis ZM4 explains physiological features and suggests ethanol and succinic acid production strategies. Microb Cell Fact (2010) 0.95